Natural products company passed double control work acceptance
Release time:
2020-07-22
Natural Products Company Passed Double Control Work Acceptance
News # July 10 , Tianjin Jianfeng Natural Products Company's double prevention mechanism construction successfully passed the acceptance of Tianjin Economic and Technological Development Zone Safety Supervision Bureau.
2018 5 , natural products company began to carry out the construction of dual prevention mechanism and set up a dual control working group, with general manager Liu Dan as the team leader and the security department as the core of the work to ensure the smooth completion of the dual control work. The double prevention mechanism is to build a double firewall to prevent production safety accidents. The first firewall is to manage risks, based on security risk identification and control, systematically identify risks from the source, manage risks at different levels, and strive to control all kinds of risks within a controllable range, so as to reduce potential accidents as much as possible; the second firewall is to control hidden dangers, taking hidden danger investigation and management as the means to carefully investigate the deficiencies, loopholes and risk control failure links in the process of risk control, resolutely eliminate hidden dangers before accidents occur.
In order to do a good job of double control, the natural products company held safety meetings at all levels and worked out implementation plans. Use meetings and publicity boards to vigorously publicize double control work; All employees participate in the identification of dangerous materials, dangerous equipment and dangerous operations related to themselves, which are reviewed by the department manager and returned for re-identification if unqualified. Through continuous identification, return, training and re-identification methods, identify all risks of the post as much as possible, and finally summarize them. Identify the risk level, divide the possibility of accident L and the severity of accident consequence S into 5 levels through LSR method, and distinguish the risk severity R with blue, yellow, orange and red colors, 1-4 is blue low risk, 5-6 is yellow general risk, 8-12 is orange large risk, 15-25 is red serious risk; Identify the existing control measures for each risk, discuss whether the existing control measures are defective and how to improve them, and rectify and supplement the missing control measures; Clarify the responsible persons for each risk control and manage them at different levels, serious risks are directly controlled by the person in charge of the Security Department, and major risks are controlled by the person in charge of each responsible department. General risks are controlled to the team leader, and low risks are controlled by the employees of each position. Assess the overall risk distribution of the company and form the company's risk distribution map and workshop risk distribution map; inform all employees of the risks and sign the risk notification letter; make post risk notification cards and notification boards and hang them on the operation site; improve the company's hidden danger investigation and management system, through various forms of investigation and management of hidden dangers. In the end, the Security Department summarized all the information and formed the "Security Risk Control and Hidden Danger Investigation and Management Manual".
Through the dual-control work, the natural product company has truly realized the bottom-up identification of safety risks, greatly improving the ability of grassroots employees to identify risks, and also greatly improving the company's ability to control safety production risks. (Xu Yiming)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page